Normal view MARC view ISBD view

Naito, Takashi

Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis. [electronic resource] - American journal of physiology. Renal physiology Mar 2010 - F683-91 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural

ISSN: 1522-1466

Standard No.: 10.1152/ajprenal.00503.2009 doi

Subjects--Topical Terms:
Angiotensin II--metabolism
Angiotensin II Type 1 Receptor Blockers--pharmacology
Angiotensin II Type 2 Receptor Blockers
Animals
Apoptosis--drug effects
Blood Pressure--drug effects
Cell Proliferation--drug effects
Cells, Cultured
Chronic Disease
Collagen--metabolism
Disease Models, Animal
Fibrinolysin--metabolism
Fibrosis
Glomerular Filtration Rate--drug effects
Imidazoles--pharmacology
Kidney--drug effects
Kidney Diseases--drug therapy
Losartan--pharmacology
Male
Mitogen-Activated Protein Kinase 1--metabolism
Mitogen-Activated Protein Kinase 3--metabolism
Nephrectomy
Phosphorylation
Plasminogen Activator Inhibitor 1--genetics
Podocytes--drug effects
Proteinuria--drug therapy
Pyridines--pharmacology
RNA, Messenger--metabolism
Rats
Rats, Sprague-Dawley
Receptor, Angiotensin, Type 2--metabolism
Time Factors